Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Aurora kinase A plays an essential role in mitosis including chromosome separation and cytokinesis. Aberrant expression and activity of Aurora kinase A is associated with numerous malignancies including colorectal cancer followed by poor prognosis. The aim of this study is to determine the inhibitory effects of LDD970, an indirubin derivative, on Aurora kinase A in HT29 colorectal cancer cells. In vitro kinase assay revealed that, LDD970 inhibited levels of activated Aurora kinase A (IC50=0.37 mM). The inhibitory effects of LDD970 on Aurora kinase A, autophosphorylation and phosphorylation of histone H3 (Ser10), were confirmed by immunoblot analysis. Moreover, LDD970 inhibited migration of HT29 cells and upregulated apoptosis-related protein cleaved PARP. In cell viability assay, LDD970 was observed to suppress HT29 cell growth (GI50=4.22 mM). Although further studies are required, results of the present study suggest that LDD970 provide a valuable insight into small molecule indirubin derivative for therapeutic potential in human colorectal cancer.
Abstract
Aurora kinase A plays an essential role in mitosis including chromosome separation and cytokinesis. Aberrant expression and activity of Aurora kinase A is associated with numerous malignancies including colorectal cancer followed by poor prognosis. The aim of this study is to determine the inhibitory effects of LDD970, an indirubin derivative, on Aurora kinase A in HT29 colorectal cancer cells. In vitro kinase assay revealed that, LDD970 inhibited levels of activated Aurora kinase A (IC50=0.37 mM). The inhibitory effects of LDD970 on Aurora kinase A, autophosphorylation and phosphorylation of histone H3 (Ser10), were confirmed by immunoblot analysis. Moreover, LDD970 inhibited migration of HT29 cells and upregulated apoptosis-related protein cleaved PARP. In cell viability assay, LDD970 was observed to suppress HT29 cell growth (GI50=4.22 mM). Although further studies are required, results of the present study suggest that LDD970 provide a valuable insight into small molecule indirubin derivative for therapeutic potential in human colorectal cancer.
참고문헌 (20)
- Giet, R., "Aurora", Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases, 1999, pp.112, 3591~3601
- Mehra, R., "Aurora kinases in head and neck cancer", Lancet Oncol, 14, pp.e425~e435 (2013)
- Dodson, C. A., "Activation of Aurora-A kinase by protein partner binding and phosphorylation are independent and synergistic", J. Biol. Chem, 287, pp.1150~1157 (2012)
- Wang, X. X., "Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line", Cell Res, 16, pp.356~366 (2006)
- Jeng, Y. M., "Overexpression and amplification of Aurora-A in hepatocellular carcinoma", Clin. Cancer Res, 10, pp.2065~2071 (2004)
- Bischoff, J. R., "A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers", EMBO J, 17, pp.3052~3065 (1998)
- Prigent, C., "Phosphorylation of serine 10 in histone H3, what for?", J. Cell Sci, 116, pp.3677~3685 (2003)
- Hans, F., "Histone H3 phosphorylation and cell division", Oncogene, 20, pp.3021~3027 (2001)
- Van, H. A., "Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation", J. Cell Sci, 111, pp.3497~3506 (1998)
- Crosio, C., "Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases", Mol. Cell. Biol, 22, pp.874~885 (2002)
- Hoessel, R., "Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases", Nat. Cell Biol, 1, pp.60~67 (1999)
- Moon, M. J., "Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities", Bioorg. Med. Chem, 14, pp.237~246 (2006)
- Gaboriaud-Kolar, N., "Indirubin derivatives: a patent review (2010-present)", Expert Opin. Ther. Pat, 25, pp.583~593 (2015)
- Chung, H. J., "Discovery of quinolinone derivatives as potent FLT3 inhibitors", Biochem. Biophys. Res. Commun, 445, pp.561~565 (2014)
- Goshima, G., "The roles of microtubulebased motor proteins in mitosis: comprehensive RNAi analysis in the Drosophila S2 cell line", J. Cell Biol, 162, pp.1003~1016 (2003)
- van Vuuren, R. J., "Antimitotic drugs in the treatment of cancer", Cancer Chemother. Pharmacol, 76, pp.1101~1112 (2015)
- Manfredi, M. G., "Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase", Proc. Natl. Acad. Sci. U. S. A, 104, pp.4106~4111 (2007)
- D'Amours, D., "Gain-of-function of poly(ADP-ribose) polymerase-1upon cleavage by apoptotic proteases: implications for apoptosis", J. Cell Sci, 114, pp.3771~3778 (2001)
- Gorgun, G., "A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma", Blood, 115, pp.5202~5213 (2010)
- Kollareddy, M., "Aurora kinase inhibitors : progress towards the clinic", Invest. New Drugs, 30, pp.2411~2432 (2012)